HealthTree Logo HealthTree Foundation
Donate

Notifications

You're all caught up

HealthTree Logo
Donate
Personal Health Record
  • My Feed
  • Recently viewed

Learn

  • Topics
  • Events

Explore

  • Find treatments & trials
  • Participate in research
  • Find a coach
  • Find a specialist
  • Talk to a patient navigator
  • Get involved
  • For researchers
  • For healthcare providers
  • About us
  • Get involved
  • For researchers
  • For healthcare providers
  • About us

Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Learn more about HealthTree
Trial match for you
Matched on subtype and prior lines
Financial help
Support program for your current medication
Coach support
Coach suggestion with your same treatment path
Video

BETA - What new strategies are being studied to overcome antibody therapy resistance in myeloma?

Posted by
HealthTree Logo HealthTree
• June 1, 2026

Description

BETA - What new strategies are being studied to overcome antibody therapy resistance in myeloma?

On this video

Healthtree contact Tarek Mouhieddine, MD

Tarek Mouhieddine, MD

Related Content

  • Video New Drug Combo for B-Cell Lymphoma: How Effective Is It? | Babis Andreadis, MD
  • Video Preventing Myeloma Relapse Using a Response Adaptive Dosing Approach | Erin Meermeier, PhD
  • Video Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD
  • Video New Hope for MRD Recurrence? Daratumumab Proof-of-Concept Study | Krzysztof Jamroziak, MD | #EHA2025
  • Video First-In-Human Study for Novel Trispecific Antibody | Rakesh Popat, BSc, MBBS, MRCP, PhD | #EHA2025
  • Video Mosunetuzumab + Polatuzumab Shows Promising Outcomes in LBCL